Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Jahn

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2018
Pediatric HIV Treatment Gaps in 7 East and Southern African Countries: Examination of Modeled, Survey, and Routine Program DataSuzue Saito, Hannah Chung, Mary Mahy, et al.
The Lancet. HIV|February 9, 2020
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelinesAndrew N Phillips, Loveleen Bansi-Matharu, Francois Venter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 9, 2021
Population Viral Load, Viremia, and Recent HIV-1 Infections: Findings From Population-Based HIV Impact Assessments (PHIAs) in Zimbabwe, Malawi, and ZambiaMansoor Farahani, Elizabeth Radin, Suzue Saito, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2025
HIV Drug Resistance to Dolutegravir Among Adults Investigated for Anti-retroviral Treatment Failure in Malawi: A 2023 National Cross-sectional SurveyNewton L Kalata, George Bello, Sherri Pals, et al.
Journal of the International AIDS Society|July 10, 2019
Cost-per-diagnosis as a metric for monitoring cost-effectiveness of HIV testing programmes in low-income settings in southern Africa: health economic and modelling analysisAndrew N Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.
The Lancet. Global Health|December 23, 2022
Cost-effectiveness of voluntary medical male circumcision for HIV prevention across sub-Saharan Africa: results from five independent modelsLoveleen Bansi-Matharu, Edinah Mudimu, Rowan Martin-Hughes, et al.
MMWR. Morbidity and Mortality Weekly Report|March 3, 2022
Geospatial Transmission Hotspots of Recent HIV Infection - Malawi, October 2019-March 2020Carson T Telford, Zaena Tessema, Malango Msukwa, et al.
Frontiers in Public Health|December 16, 2020
Protocol for a Case-Control Study to Investigate the Association of Pellagra With Isoniazid Exposure During Tuberculosis Preventive Treatment Scale-Up in MalawiScott A Nabity, Kelvin Mponda, Steve Gutreuter, et al.
Journal of the International AIDS Society|November 23, 2020
Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveysAndreas D Haas, Elizabeth Radin, Avi J Hakim, et al.
Journal of the International AIDS Society|September 21, 2021
Naomi: a new modelling tool for estimating HIV epidemic indicators at the district level in sub-Saharan AfricaJeffrey W Eaton, Laura Dwyer-Lindgren, Steve Gutreuter, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2018
Pediatric HIV Treatment Gaps in 7 East and Southern African Countries: Examination of Modeled, Survey, and Routine Program DataSuzue Saito, Hannah Chung, Mary Mahy, et al.
The Lancet. HIV|February 9, 2020
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelinesAndrew N Phillips, Loveleen Bansi-Matharu, Francois Venter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 9, 2021
Population Viral Load, Viremia, and Recent HIV-1 Infections: Findings From Population-Based HIV Impact Assessments (PHIAs) in Zimbabwe, Malawi, and ZambiaMansoor Farahani, Elizabeth Radin, Suzue Saito, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2025
HIV Drug Resistance to Dolutegravir Among Adults Investigated for Anti-retroviral Treatment Failure in Malawi: A 2023 National Cross-sectional SurveyNewton L Kalata, George Bello, Sherri Pals, et al.
Journal of the International AIDS Society|July 10, 2019
Cost-per-diagnosis as a metric for monitoring cost-effectiveness of HIV testing programmes in low-income settings in southern Africa: health economic and modelling analysisAndrew N Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.
The Lancet. Global Health|December 23, 2022
Cost-effectiveness of voluntary medical male circumcision for HIV prevention across sub-Saharan Africa: results from five independent modelsLoveleen Bansi-Matharu, Edinah Mudimu, Rowan Martin-Hughes, et al.
MMWR. Morbidity and Mortality Weekly Report|March 3, 2022
Geospatial Transmission Hotspots of Recent HIV Infection - Malawi, October 2019-March 2020Carson T Telford, Zaena Tessema, Malango Msukwa, et al.
Frontiers in Public Health|December 16, 2020
Protocol for a Case-Control Study to Investigate the Association of Pellagra With Isoniazid Exposure During Tuberculosis Preventive Treatment Scale-Up in MalawiScott A Nabity, Kelvin Mponda, Steve Gutreuter, et al.
Journal of the International AIDS Society|November 23, 2020
Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveysAndreas D Haas, Elizabeth Radin, Avi J Hakim, et al.
Journal of the International AIDS Society|September 21, 2021
Naomi: a new modelling tool for estimating HIV epidemic indicators at the district level in sub-Saharan AfricaJeffrey W Eaton, Laura Dwyer-Lindgren, Steve Gutreuter, et al.
Pageof 16